Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Oral Lesions 1Neoplasms 1Mouth Neoplasms 1Laryngeal Diseases 1Head and Neck Neoplasms 1Carcinoma, Squamous Cell 1

Interventions

Colposcopy 17Methods 14Early Intervention, Educational 12Cisplatin 12Brachytherapy 11Human Papillomavirus DNA Tests 10Blood Specimen Collection 10Educational Status 9Biopsy 8Standard of Care 7Radiotherapy 7Patient Navigation 7Papanicolaou Test 7Magnetic Resonance Spectroscopy 7Vaginal Smears 6Sentinel Lymph Node Biopsy 6Mass Screening 6Counseling 6Acetic Acid 6Watchful Waiting 5Surveys and Questionnaires 5Radiotherapy, Intensity-Modulated 5Therapeutics 4Specimen Handling 4Radiation Dose Hypofractionation 4Practice Guidelines as Topic 4Paclitaxel 4Transurethral Resection of Prostate 3Radiation 3Psychiatric Rehabilitation 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Uterine Cervical Neoplasms × Proflavine × Clear all
NCT02206048 2022-07-25

Use of High-Resolution Microendoscopy (HRME) in Patients With Adenocarcinoma In-Situ (AIS) of the Cervix

M.D. Anderson Cancer Center

Phase NA Completed
9 enrolled 5 charts
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡